Eleventh-Hour Settlement in Cialis Patent Suit Clears Path for Generics

, The National Law Journal

   | 1 Comments

Generic drug makers, including Teva, had been set to go to trial Monday against Eli Lilly & Co. The deal ends Lilly's exclusivity over Cialis in 2018.

This premium content is reserved for National Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

  • jaslopminn

    I discovered the best trading method to make money, and it helped me become a successful trader. Simple Google Superior Trading System to know more about it.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202793119867

Thank you!

This article's comments will be reviewed.